novo nordisk pfizer - Search News

Pfizer sues Metsera, Novo Nordisk

Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera

Another quarterly earnings announcement from Novo Nordisk and another downgrade to earnings guidance from the Danish pharmaceuticals company, the fourth this year.

Pharmaceutical Technology · 29m

Novo Nordisk and Pfizer’s bidding war for Metsera escalates despite legal threats

· 20h · on MSN

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

· 19h

Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo

A Delaware judge said on Tuesday she did not see in a preliminary evaluation the need to involve the court in the bidding war for Metsera between Pfizer and Novo Nordisk, but did schedule another hea...

· 19h

Pfizer & Novo boost Metsera bids, Hertz stock skyrockets

· 1d

Pfizer accuses Novo Nordisk of anticompetitive plot to stall Metsera deal in lawsuit

26m

Novo Nordisk's Medicare deal takes heat off Wegovy slowdown

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and sales forecasts on Wednesday as sales growth slows, but investors cheered a better-than-expected Medicare pricing deal that helped lift the shares after an initial slide.

Devdiscourse

Novo Nordisk Under Siege: Battle for Weight-Loss Drug Supremacy

Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly, has significantly impacted its market position, leading to substantial financial losses.

Novo Nordisk cuts profit forecast as new CEO faces rocky start

Novo Nordisk lowers its 2025 profit forecast as new CEO Mike Doustdar faces rising competition, leadership changes, and a tense takeover battle with Pfizer.